Reworking Protocols in the Ophthalmology Department during the COVID-19 Crisis
Eye care professionals are susceptible to contract COVID-19 infection due to the presence of the virus in tears and conjunctival secretions and, also, partly due to the proximity required during ophthalmic examination. Although infrequent, ocular features include conjunctivitis (predominant), chemosis, follicles, itching, dry eye, and tearing. In this article, we have outlined salient safety recommendations at outpatient, inpatient and operation theater level for both patients as well as health care workers. Some of them being, creation of special triage areas at ophthalmology clinic for the screening of patients, things to be avoided at each level, procedures to manage appointments, examination room modifications, operation theater protocols, a suggestion for prioritizing cases, and finally airflow and hospital staff management. These suggestions, along with local hospital-specific modifications, will help us to go a long way in the battle against COVID-19.
24 June 2020 (online)
Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India
- 1 Siedlecki J, Brantl V, Schworm B. et al. COVID-19: ophthalmological aspects of the SARS-CoV 2 global pandemic. Klin Monbl Augenheilkd 2020; 237 (05) 675-680
- 2 Hu K, Patel J, Patel BC. Ophthalmic Manifestations Of Coronavirus (COVID-19). StatPearls Publishing;2020. Available at: http://www.ncbi.nlm.nih.gov/books/NBK556093/. Accessed May 10, 2020
- 3 Parrish II RK, Stewart MW, Duncan Powers SL. Ophthalmologists are more than eye doctors-in memoriam Li Wenliang. Am J Ophthalmol 2020; 213: A1-A2
- 4 Seah I, Su X, Lingam G. Revisiting the dangers of the coronavirus in the ophthalmology practice. Eye (Lond) 2020; DOI: 10.1038/s41433-020-0790-7.
- 5 Lu C-W, Liu X-F, Jia Z-F. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet 2020; 395 (10224) e39
- 6 Guan W-J, Ni Z-Y, Hu Y. et al. China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020; 382 (18) 1708-1720
- 7 Wu P, Duan F, Luo C. et al. Characteristics of ocular findings of patients with Coronavirus disease 2019 (COVID-19) in Hubei province, China. JAMA Ophthalmol 2020; DOI: 10.1001/jamaophthalmol.2020.1291.
- 8 Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol 2020; DOI: 10.1002/jmv.25725.
- 9 Chen L, Liu M, Zhang Z. et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol 2020; 104 (06) 748-751
- 10 Scalinci SZ, Trovato Battagliola E. Conjunctivitis can be the only presenting sign and symptom of COVID-19. IDCases 2020; 20: e00774
- 11 Cheema M, Aghazadeh H, Nazarali S. et al. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19).. Can J Ophthalmol 2020; DOI: 10.1016/j.jcjo.2020.03.003.
- 12 Daruich A, Martin D, Bremond-Gignac D. Ocular manifestation as first sign of Coronavirus Disease 2019 (COVID-19): Interest of telemedicine during the pandemic context. J Fr Ophtalmol 2020; 43 (05) 389-391
- 13 Navel V, Chiambaretta F, Dutheil F. Haemorrhagic conjunctivitis with pseudomembranous related to SARS-CoV-2. Am J Ophthalmol Case Rep 2020; DOI: 10.1016/j.ajoc.2020.100735.
- 14 Ulhaq ZS, Soraya GV. The prevalence of ophthalmic manifestations in COVID-19 and the diagnostic value of ocular tissue/fluid. Graefes Arch Clin Exp Ophthalmol 2020; 258 (06) 1351-1352
- 15 Guo Y-R, Cao Q-D, Hong Z-S. et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res 2020; 7 (01) 11
- 16 Lim LW, Yip LW, Tay HW. et al. Sustainable practice of ophthalmology during COVID-19: challenges and solutions. Graefes Arch Clin Exp Ophthalmol 2020; DOI: 10.1007/s00417-020-04682-z.
- 17 Sengupta S, Honavar SG, Sachdev MS. et al. Writing Committee on behalf of the All India Ophthalmological Society - Indian Journal of Ophthalmology Expert Group for COVID-19 Practice Guidelines; Composition of the All India Ophthalmological Society - Indian Journal of Ophthalmology Expert Group for COVID-19 Practice Guidelines includes the Writing Committee (as listed) and the following members (in alphabetical order by the first name). All India Ophthalmological Society - Indian Journal of Ophthalmology consensus statement on preferred practices during the COVID-19 pandemic. Indian J Ophthalmol 2020; 68 (05) 711-724
- 18 Lai TH, Tang EWH, Chau SKY, Fung KSC, Li KK. Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong. Graefes Arch Clin Exp Ophthalmol 2020; 258 (05) 1049-1055
- 19 Khanna RC, Honavar SG. All eyes on Coronavirus-What do we need to know as ophthalmologists. Indian J Ophthalmol 2020; 68 (04) 549-553
- 20 COVID-19 Guidance Document for Air Conditioning and Ventilation. AICTE- India.org. Available at: https://www.aicte-india.org/. Accessed May 16, 2020
- 21 Loon S-C, Teoh SCB, Oon LL. et al. The severe acute respiratory syndrome coronavirus in tears. Br J Ophthalmol 2004; 88 (07) 861-863
- 22 Nishiura H, Kobayashi T, Miyama T. et al. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). Int J Infect Dis 2020; 94: 154-155
- 23 Du H, Zhang M, Zhang H, Sun X. Practical experience on emergency ophthalmic surgery during the prevalence of COVID-19. Graefes Arch Clin Exp Ophthalmol 2020; DOI: 10.1007/s00417-020-04692-x.
- 24 Coccolini F, Perrone G, Chiarugi M. et al. Surgery in COVID-19 patients: operational directives. World J Emerg Surg 2020; 15 (01) 25
- 25 Ti LK, Ang LS, Foong TW, Ng BSW. What we do when a COVID-19 patient needs an operation: operating room preparation and guidance. Can J Anaesth 2020; 67 (06) 756-758
- 26 Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLoS One 2012; 7 (04) e35797
- 27 Korobelnik J-F, Loewenstein A, Eldem B. et al. Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic. Graefes Arch Clin Exp Ophthalmol 2020; 258 (06) 1149-1156